Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-04-23

Clinical Trial Update: Efficacy and Safety of G001 in Patients With Osteoarthritis (OA) of the Knee [Phase 2]

View source ↗

Summary

Phase 2 trial results for G001 in knee osteoarthritis have been completed with posted results evaluating efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • G001

Snippet

Sponsor: BUZZZ Pharmaceuticals Limited | Conditions: Osteoarthritis, Knee | Phase 2 | Status: COMPLETED | Results posted: 2024-04-23